Mitochondrial DNA Haplogroups and Susceptibility to Prostate Cancer in a Colombian Population

Table 1

Clinical-pathological characteristics of Colombian prostate cancer patients and the control group.

Characteristic	Category	PC patients (𝑛=168)	Controls (𝑛=140)
Mean (SD^1) age		68.02 (9.18)	62.62 (11.97)
		𝑛=162	𝑛=133
Mean (SD^1) PSA^2		2.16 (0.87)	1.12 (0.39)
		𝑛=160	𝑛=140
	≤4	35 (21.9%)	125 (89.3%)
	4.1–10.0	79 (49.4%)	12 (8.6%)
	10.1–20.0	31 (19.4%)	3 (2.1%)
	>20	15 (9.3%)	0 (0.0%)
Gleason score		𝑛=155	—
	Gleason score < 7	100 (64.5%)	—
	Gleason score ≥ 7	55 (35.5%)	—
TMN		𝑛=146	—
	T1	54 (37.0%)	—
	T2	58 (39.7%)	—
	T3	30 (20.5%)	—
	T4	4 (2.8%)	—

1SD: standard deviation.
2PSA: prostate-specific antigen.